Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human immunodeficiency virus type 1 phenotypes in children with advanced disease treated with long-term zalcitabine.

The Journal of infectious diseases - 1 Mar 1998

Viani R M, Smith I L, Spector S A

Abstract excerpt

Baseline and posttreatment human immunodeficiency virus type 1 (HIV-1) isolates from 38 symptomatic, zidovudine-experienced HIV-1-infected children enrolled in a prospective trial of zalcitabine (dideoxycytidine) monotherapy (Pediatric AIDS Clinical Trials Group 138) were studied for the presence...

Topics

Adolescent
Anti-HIV Agents
Child
Child, Preschool
Cohort Studies
Drug Resistance, Microbial
HIV Infections
HIV-1
Humans
Infant
Phenotype
Reverse Transcriptase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Time Factors

Zalcitabine

Source

Identifiers

PMID: 9498433
DOI: 10.1086/514238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9498433-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human immunodeficiency virus type 1 phenotypes in children with advanced disease treated with long-term zalcitabine.PMID 9498433Read ↗

Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.Semantic proximity Read ↗

Resistance to (-)-2',3'-dideoxy-3'-thiacytidine (3TC) in HIV-1 isolated from paediatric patients.Semantic proximity Read ↗

HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.Semantic proximity Read ↗

Viral phenotype, antiretroviral resistance and clinical evolution in human immunodeficiency virus-infected children.Semantic proximity Read ↗

Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure: a clonal analysis.Semantic proximity Read ↗

HIV type 1 phenotype correlates with the stage of infection in vertically infected children.Semantic proximity Read ↗

The role of HIV type 1 phenotype and genotype in long-term responders to zidovudine therapy.Semantic proximity Read ↗

Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected children.Semantic proximity Read ↗

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.Semantic proximity Read ↗

Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people.Semantic proximity Read ↗

Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group.Semantic proximity Read ↗

Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.